These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7202343)

  • 1. Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects.
    Swabb EA; Sugerman AA; Platt TB; Pilkiewicz FG; Frantz M
    Antimicrob Agents Chemother; 1982 Jun; 21(6):944-9. PubMed ID: 7202343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects.
    Swabb EA; Sugerman AA; McKinstry DN
    Antimicrob Agents Chemother; 1983 Jan; 23(1):125-32. PubMed ID: 6681947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of single- and multiple-dose pharmacokinetics of the monobactam, aztreonam (SQ 26,776) in healthy subjects.
    Swabb EA; Sugerman AA
    Chemotherapy; 1983; 29(5):313-21. PubMed ID: 6684541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and pharmacokinetics of aztreonam in healthy subjects.
    Swabb EA; Singhvi SM; Leitz MA; Frantz M; Sugerman A
    Antimicrob Agents Chemother; 1983 Sep; 24(3):394-400. PubMed ID: 6685455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of the monobactam SQ 26,776 after single intravenous doses in healthy subjects.
    Swabb EA; Leitz MA; Pilkiewicz FG; Sugerman AA
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():131-40. PubMed ID: 7199041
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal handling of the monobactam azthreonam in healthy subjects.
    Swabb EA; Sugerman AA; Frantz M; Platt TB; Stern M
    Clin Pharmacol Ther; 1983 May; 33(5):609-14. PubMed ID: 6682362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and tissue penetration of azthreonam.
    Wise R; Dyas A; Hegarty A; Andrews JM
    Antimicrob Agents Chemother; 1982 Dec; 22(6):969-71. PubMed ID: 6891575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramuscular and intravenous pharmacokinetics of cefmenoxime, a new broad-spectrum cephalosporin, in healthy subjects.
    Granneman GR; Sennello LT; Steinberg FJ; Sonders RC
    Antimicrob Agents Chemother; 1982 Jan; 21(1):141-5. PubMed ID: 6282203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans.
    Weidekamm E; Stoeckel K; Egger HJ; Ziegler WH
    Antimicrob Agents Chemother; 1984 Dec; 26(6):898-902. PubMed ID: 6395801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of aztreonam after intravenous infusion.
    Scully BE; Swabb EA; Neu HC
    Antimicrob Agents Chemother; 1983 Jul; 24(1):18-22. PubMed ID: 6684898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of aztreonam in patients with chronic renal failure.
    Fillastre JP; Leroy A; Baudoin C; Humbert G; Swabb EA; Vertucci C; Godin M
    Clin Pharmacokinet; 1985; 10(1):91-100. PubMed ID: 4038635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria.
    Sykes RB; Bonner DP; Bush K; Georgopapadakou NH
    Antimicrob Agents Chemother; 1982 Jan; 21(1):85-92. PubMed ID: 6979307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral bioavailability of the monobactam aztreonam (SQ 26,776) in healthy subjects.
    Swabb EA; Sugerman AA; Stern M
    Antimicrob Agents Chemother; 1983 Apr; 23(4):548-50. PubMed ID: 6683094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose pharmacokinetics of 3-O-demethylfortimicin A in humans after intravenous and intramuscular administration.
    Sennello LT; Wilson DS; Afarian J; Holtam LS; Norman G; Rollins DE; Tolman KG
    Antimicrob Agents Chemother; 1986 Mar; 29(3):400-4. PubMed ID: 3717941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose pharmacokinetics of aztreonam in pediatric patients.
    Stutman HR; Marks MI; Swabb EA
    Antimicrob Agents Chemother; 1984 Aug; 26(2):196-9. PubMed ID: 6541452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam.
    McNulty CA; Garden GM; Ashby J; Wise R
    Antimicrob Agents Chemother; 1985 Sep; 28(3):425-7. PubMed ID: 4073864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction.
    Mihindu JC; Scheld WM; Bolton ND; Spyker DA; Swabb EA; Bolton WK
    Antimicrob Agents Chemother; 1983 Aug; 24(2):252-61. PubMed ID: 6685452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of aztreonam pharmacokinetics in humans based on data from animals.
    Swabb EA; Bonner DP
    J Pharmacokinet Biopharm; 1983 Jun; 11(3):215-23. PubMed ID: 6685766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aztreonam in human serum and breast milk.
    Fleiss PM; Richwald GA; Gordon J; Stern M; Frantz M; Devlin RG
    Br J Clin Pharmacol; 1985 Apr; 19(4):509-11. PubMed ID: 4039600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity and human pharmacokinetics of teicoplanin.
    Verbist L; Tjandramaga B; Hendrickx B; Van Hecken A; Van Melle P; Verbesselt R; Verhaegen J; De Schepper PJ
    Antimicrob Agents Chemother; 1984 Dec; 26(6):881-6. PubMed ID: 6240962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.